Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewa Budzynski

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Human Gene Therapy|November 26, 2015
Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal DiseasesGuo-Jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
The Journal of Biological Chemistry|March 9, 2010
Mutations of the opsin gene (Y102H and I307N) lead to light-induced degeneration of photoreceptors and constitutive activation of phototransduction in miceEwa Budzynski, Alecia K Gross, Suzanne D McAlear, et al.
Human Gene Therapy. Clinical Development|September 22, 2015
Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing RetinoschisinGuo-Jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Plos One|May 14, 2015
Visual Cycle Modulation as an Approach toward Preservation of Retinal IntegrityClaes Bavik, Susan Hayes Henry, Yan Zhang, et al.
Human Gene Therapy. Clinical Development|March 23, 2016
Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of AchromatopsiaGuo-jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Human Gene Therapy. Clinical Development|March 23, 2016
Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of AchromatopsiaGuo-jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Human Gene Therapy|November 26, 2015
Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal DiseasesGuo-Jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
The Journal of Biological Chemistry|March 9, 2010
Mutations of the opsin gene (Y102H and I307N) lead to light-induced degeneration of photoreceptors and constitutive activation of phototransduction in miceEwa Budzynski, Alecia K Gross, Suzanne D McAlear, et al.
Human Gene Therapy. Clinical Development|September 22, 2015
Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing RetinoschisinGuo-Jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Plos One|May 14, 2015
Visual Cycle Modulation as an Approach toward Preservation of Retinal IntegrityClaes Bavik, Susan Hayes Henry, Yan Zhang, et al.
Human Gene Therapy. Clinical Development|March 23, 2016
Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of AchromatopsiaGuo-jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Human Gene Therapy. Clinical Development|March 23, 2016
Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of AchromatopsiaGuo-jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Pageof 2